This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1vyq
From Proteopedia
| Line 1: | Line 1: | ||
| - | == | + | |
| + | ==Novel inhibitors of Plasmodium Falciparum dUTPase provide a platform for anti-malarial drug design== | ||
<StructureSection load='1vyq' size='340' side='right' caption='[[1vyq]], [[Resolution|resolution]] 2.40Å' scene=''> | <StructureSection load='1vyq' size='340' side='right' caption='[[1vyq]], [[Resolution|resolution]] 2.40Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| Line 5: | Line 6: | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=DUX:2,3-DEOXY-3-FLUORO-5-O-TRITYLURIDINE'>DUX</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=DUX:2,3-DEOXY-3-FLUORO-5-O-TRITYLURIDINE'>DUX</scene></td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/dUTP_diphosphatase dUTP diphosphatase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.6.1.23 3.6.1.23] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/dUTP_diphosphatase dUTP diphosphatase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.6.1.23 3.6.1.23] </span></td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1vyq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1vyq OCA], [http://pdbe.org/1vyq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=1vyq RCSB], [http://www.ebi.ac.uk/pdbsum/1vyq PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1vyq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1vyq OCA], [http://pdbe.org/1vyq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=1vyq RCSB], [http://www.ebi.ac.uk/pdbsum/1vyq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=1vyq ProSAT]</span></td></tr> |
</table> | </table> | ||
== Evolutionary Conservation == | == Evolutionary Conservation == | ||
| Line 11: | Line 12: | ||
Check<jmol> | Check<jmol> | ||
<jmolCheckbox> | <jmolCheckbox> | ||
| - | <scriptWhenChecked>select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/vy/1vyq_consurf.spt"</scriptWhenChecked> | + | <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/vy/1vyq_consurf.spt"</scriptWhenChecked> |
<scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked> | ||
<text>to colour the structure by Evolutionary Conservation</text> | <text>to colour the structure by Evolutionary Conservation</text> | ||
Revision as of 07:44, 4 April 2018
Novel inhibitors of Plasmodium Falciparum dUTPase provide a platform for anti-malarial drug design
| |||||||||||
Categories: Plaf7 | DUTP diphosphatase | Bell, E | Benito, A | Berry, C | Brun, R | Dodson, E J | Gilbert, I H | Johansson, N G | Jones, A F | Kasinathan, G | Leal, I | Nguyen, C | Pacanowska, D Gonzalez | Perez, L M.Ruiz | Turkenburg, J P | Whittingham, J L | Wilkinson, A J | Wilson, K S | Deoxyuridine nucleotidohydrolase | Drug design | Dutpase | Hydrolase | Malaria | Plasmodium falciparum

